Bacterial Infection Due to Helicobacter Pylori (H. Pylori) Clinical Trial
Official title:
Epidemiology of Helicobacter Pylori Infection Among Shanghai Children
Verified date | August 2016 |
Source | Children's Hospital of Fudan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | China: Ministry of Health |
Study type | Observational |
Epidemiology of Helicobacter Pylori Infection Among Shanghai Children.
Status | Completed |
Enrollment | 1997 |
Est. completion date | June 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 3 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Age 3~18 - Not been Clinical diagnosis of Exclusion Criteria: - Had antibiotics in the past week - Had Bismuth or PPI |
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
China | Pujiang Community Health Service Center | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Children's Hospital of Fudan University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HP Infection Rate Estimation for Shanghai Children | Get the population of infection with HP and calculate the infection rate for the sampling group, to estimate the infection rate for whole population of Shanghai children | Sampling complete before June 30, 2014. Lab test finish within 10 weeks. Report release within 3 weeks after all test finished. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02553083 -
High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
|
Phase 4 | |
Completed |
NCT01897909 -
The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana
|
||
Completed |
NCT03367897 -
Bleeding Ulcer and Erosions Study "BLUE Study"
|
||
Completed |
NCT01506986 -
Helicobacter Eradication Aspirin Trial
|
Phase 4 | |
Recruiting |
NCT01572597 -
Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
|
Phase 4 | |
Recruiting |
NCT02164409 -
Changes Associated With H. Pylori and Gastric Carcinogenesis
|
||
Completed |
NCT01623154 -
POCone-UBiT-IR300 Pediatric Comparison Study
|
Phase 4 | |
Completed |
NCT01591486 -
Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding
|
N/A | |
Completed |
NCT03124199 -
Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
|
Phase 3 | |
Recruiting |
NCT02674802 -
Reinfection After Eradication of Helicobacter Pylori Infection
|
N/A | |
Completed |
NCT02092506 -
RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
|
Phase 4 | |
Completed |
NCT01902589 -
Resistance of Helicobacter Pylori to Antibiotics in Children
|
N/A |